This issue brief, developed by the SAMHSA SOAR TA Center, explores ways that agencies can involve AmeriCorps members at low or no cost to help implement SOAR.
This issue brief, developed by the SAMHSA SOAR TA Center, provides strategies for forming partnerships, examples, and a sample agreement to help hospitals and community programs create collaborations that are mutually beneficial.
How substance use is considered in the disability determination process has changed substantially over the years. This article dispels several widely-held myths about how DDS views substance use (such as you have to be clean and sober to get benefits), and its impact on the application process.
In this two-part webinar series, held on October 18 and 25, 2017, presenters shared their knowledge of opioid use disorders, opioid misuse and marijuana use among individuals experiencing homelessness.
Understanding the Social Security Administration’s evaluation criteria for SSI/SSDI applications involving co-occurring disorders is critical to providing effective representation.
This webinar, held on August 23, 2023, addressed the concept of “materiality” and how to demonstrate to DDS that past or ongoing substance use is not material to a finding of disability
The CE report should show not only the individual’s symptoms, laboratory findings (psychological test results), and diagnosis but also the effect of the mental disorder on the individual’s ability to function in personal, social, and occupational situations.
Completing the SSA-827 allows SOAR case managers to obtain the applicant’s medical records, in order to verify that they meet the medical eligibility criteria for SSI/SSDI.